RELAY THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.37 USD | +3.49% |
|
+6.88% | -42.14% |
| 03-12 | Transcript : Relay Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM | |
| 02-23 | Relay Therapeutics Q4 Loss Widens, Reports No Revenue | MT |
Chart calendar Relay Therapeutics, Inc.
9b04842da57b856c7f4a5d2.NmCcdpCCnb8w_Y3xFYm55HvAH-Tuqaoz9t7ektmRyKA.cjnyReXl3v15if-aR9_ruxCUWpXanZxFzpqo4o_breJzGqU4wejIy0TK5g~a358933dc16c57f4bac37075b081f6ec
Upcoming events on Relay Therapeutics, Inc.
Past events on Relay Therapeutics, Inc.
| 17/04/2024 18:25 | Stifel Virtual Targeted Oncology Days Conference |
| 12/03/2024 11:30 | Barclays Global Healthcare Conference |
| 11/03/2024 14:40 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 15:30 | TD Cowen Health Care Conference |
| 22/02/2024 21:05 | Q4 2023 Earnings Release |
| 08/02/2024 15:30 | Guggenheim Healthcare Talks Biotechnology Conference |
| 09/01/2024 22:15 | JPMorgan Healthcare Conference |
| 14/11/2023 18:50 | Stifel Healthcare Conference |
| 02/11/2023 20:05 | Q3 2023 Earnings Release |
| 12/10/2023 22:30 | AACR-NCI-EORTC International Conference |
| 08/08/2023 21:02 | Q2 2023 Earnings Release |
| 13/06/2023 18:00 | Goldman Sachs Global Healthcare Conference |
| 03/06/2023 | American Society of Clinical Oncology Conference |
| 30/05/2023 | Annual General Meeting |
| 30/05/2023 18:00 | TD Cowen Oncology Innovation Summit |
| 09/05/2023 18:00 | Bank of America Healthcare Conference |
| 04/05/2023 21:05 | Q1 2023 Earnings Release |
| 26/04/2023 17:30 | Stifel Targeted Oncology Days |
| 18/04/2023 18:30 | American Association for Cancer Research Meeting |
| 15/03/2023 20:05 | Barclays Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 82,7 44,0 87.85% | 3,03 5,78 -47.62% | 1,38 4,43 -68.83% | 25,5 22,1 15.54% | 0,40 |
|
EBITDA Million USD | Released Forecast Spread | -52,2 -86,2 39.35% | -358 -359 0.32% | -295 -308 4.16% | -368 -373 1.5% | -383 |
|
EBIT Million USD | Released Forecast Spread | -55,8 -83,0 32.8% | -362 -358 -1.1% | -299 -313 4.26% | -373 -377 1.05% | -392 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,4 -174 69.89% | -364 -350 -3.83% | -291 -308 5.78% | -342 -355 3.57% | -375 |
|
Net income Million USD | Released Forecast Spread | -230 -263 12.44% | -364 -352 -3.24% | -291 -309 6.07% | -342 -354 3.51% | -372 |
|
EPS USD | Released Forecast Spread | -5,40 -4,81 -12.26% | -3,82 -3,73 -2.38% | -2,59 -2,75 5.83% | -2,79 -2,89 3.29% | -2,88 |
| Announcement Date | 25/03/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,57 4,50 -87.4% | 0,42 0,00 - | 0,37 2,08 -82.48% | 0,34 2,06 -83.28% | 0,25 0,18 44.57% | 0,23 0,16 43.04% | 0,12 0,66 -82.05% | 25,2 0,41 6016.99% | 0,00 0,61 - | 0,11 | 0,92 | 0,94 | 1,27 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -65,9 -58,6 -12.38% | -100,0 -70,3 -42.2% | -105 -91,0 -15.07% | -72,2 -107 32.28% | -90,8 -93,5 2.83% | -85,4 | -85,2 | -82,8 | -80,4 | -86,9 | ||||
|
EBIT Million USD | Released Forecast Spread | -66,9 -61,1 -9.46% | -62,7 -68,0 7.7% | -77,8 -70,1 -10.96% | -85,9 -77,2 -11.3% | -72,9 -89,1 18.26% | -101 -84,9 -19.22% | -106 -104 -1.58% | -73,6 -106 30.74% | -92,2 -91,8 -0.4% | -96,2 | -99,6 | -98,0 | -97,4 | -87,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -67,5 -48,1 -40.24% | -62,0 -68,2 9.02% | -76,8 -64,1 -19.74% | -84,2 -76,4 -10.19% | -67,5 -84,9 20.47% | -94,2 -83,9 -12.35% | -98,5 -99,3 0.84% | -65,7 -99,3 33.81% | -83,5 -85,0 1.73% | -89,2 | -91,7 | -91,2 | -91,6 | -87,8 |
|
Net income Million USD | Released Forecast Spread | -67,5 -53,7 -25.57% | -62,0 -68,2 9% | -76,8 -64,1 -19.74% | -84,2 -76,4 -10.19% | -67,5 -87,4 22.78% | -94,2 -84,2 -11.9% | -98,5 -99,9 1.4% | -65,7 -101 35.19% | -83,5 -89,0 6.15% | -88,3 | -90,9 | -91,5 | -92,8 | -87,8 |
|
EPS USD | Released Forecast Spread | -0,62 -0,55 -11.77% | -0,57 -0,62 7.74% | -0,71 -0,63 -12.97% | -0,76 -0,70 -8.62% | -0,56 -0,70 20.18% | -0,78 -0,69 -12.84% | -0,81 -0,83 2.02% | -0,54 -0,83 34.9% | -0,67 -0,73 7.95% | -0,70 | -0,73 | -0,72 | -0,70 | -0,64 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 08/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Relay Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RLAY Stock
- Calendar Relay Therapeutics, Inc.
